Investment in Gensel

Genus PLC 16 March 2001 FOR IMMEDIATE RELEASE 16 March 2001 GENUS PLC ADDITIONAL INVESTMENT IN GENSEL BIOTECHNOLOGIES LTD Genus PLC, the AIM listed agriculture and technology company announces that it is to exercise some of its outstanding warrants in Gensel Biotechnologies Ltd., by purchasing 429,082 shares in Gensel at C$0.35 per share for a total investment of C$150,178.70. Gensel, based in Canada, is an agricultural biotechnologies company focusing on technologies to improve productivity and value-added traits in livestock. Its first platform technology is sperm sexing that will allow producers to pre-select the gender of offspring prior to conception resulting in significant productivity gains for breeders an producers. Contact: Richard Wood Genus plc 01270 536501 Charles Ryland Buchanan Communications 020 7466 5000

Companies

Genus (GNS)
UK 100